ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 150 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $326,000 | -38.1% | 6,291 | -15.0% | 0.01% | -40.0% |
| Q1 2022 | $527,000 | +3.9% | 7,399 | +9.1% | 0.01% | -23.1% |
| Q4 2021 | $507,000 | +113.9% | 6,779 | +62.6% | 0.01% | +225.0% |
| Q3 2021 | $237,000 | -37.8% | 4,169 | -51.9% | 0.00% | -42.9% |
| Q2 2021 | $381,000 | +28.3% | 8,664 | +44.1% | 0.01% | +40.0% |
| Q1 2021 | $297,000 | -61.1% | 6,012 | -64.0% | 0.01% | -78.3% |
| Q3 2020 | $764,000 | -30.5% | 16,698 | -23.8% | 0.02% | -56.6% |
| Q2 2020 | $1,100,000 | – | 21,916 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 476,042 | $45,472,000 | 12.29% |
| Stonepine Capital Management, LLC | 60,840 | $5,811,000 | 3.34% |
| ACUTA CAPITAL PARTNERS, LLC | 61,000 | $5,827,000 | 2.77% |
| Virtus ETF Advisers LLC | 10,634 | $1,016,000 | 2.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $5,827,000 | 2.15% |
| ARMISTICE CAPITAL, LLC | 372,000 | $35,533,000 | 1.94% |
| Matarin Capital Management, LLC | 209,403 | $20,002,000 | 1.46% |
| Monashee Investment Management LLC | 50,000 | $4,776,000 | 1.10% |
| Granahan Investment Management | 151,322 | $14,454,000 | 0.78% |
| ALGERT GLOBAL LLC | 13,186 | $1,260,000 | 0.72% |